Deprecated: Creation of dynamic property Responsive_Lightbox_Lite::$choices is deprecated in /var/www/vhosts/lifecare.attme.dev/httpdocs/wp-content/plugins/responsive-lightbox-lite/responsive-lightbox-lite.php on line 470

Deprecated: Creation of dynamic property Responsive_Lightbox_Lite::$loading_places is deprecated in /var/www/vhosts/lifecare.attme.dev/httpdocs/wp-content/plugins/responsive-lightbox-lite/responsive-lightbox-lite.php on line 475
Stock market announcements Archive - Page 9 of 27 - Lifecare
Deprecated: Creation of dynamic property WP_Thumb::$_file_path is deprecated in /var/www/vhosts/lifecare.attme.dev/httpdocs/wp-content/plugins/wp-thumb/wpthumb.php on line 111

Deprecated: Creation of dynamic property WP_Thumb::$_file_path is deprecated in /var/www/vhosts/lifecare.attme.dev/httpdocs/wp-content/plugins/wp-thumb/wpthumb.php on line 111

Deprecated: Creation of dynamic property WP_Thumb::$_file_path is deprecated in /var/www/vhosts/lifecare.attme.dev/httpdocs/wp-content/plugins/wp-thumb/wpthumb.php on line 111

Deprecated: Creation of dynamic property WP_Thumb::$_file_path is deprecated in /var/www/vhosts/lifecare.attme.dev/httpdocs/wp-content/plugins/wp-thumb/wpthumb.php on line 111

Stock market announcement archive

Lifecare Q4 2023 Report – Steady course

February 27, 2024
Bergen, Norway, February 27th, 2024: Today, Lifecare AS (LIFE) (the “Company”), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), publishes Q4 financial report and operational update. Lifecare holds steady a course towards the upcoming automated pilot production. The first three quarters of 2023, Lifecare reported on huge achievements both […]
Read more

Lifecare Q4 2023 report and webcast

February 26, 2024
Lifecare AS will present Q4 2023 financial and operational status in a webcast Tuesday 27 February. The webcast will be for all shareholders and interested parties at 12:00 – 12:45 CET. Lifecare’s CEO Joacim Holter presents the company’s Q4 report followed by a Q&A session where Holter will answer questions submitted in advance. Questions in […]
Read more

LIFE – Lifecare will prepare for uplisting to the main list on Oslo Stock Exchange

February 21, 2024
Bergen, Norway, February 21st, 2024: Lifecare AS (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), announces today that the Board of Directors has decided to prepare for submitting application for listing of Lifecare’s shares at the main list of Oslo Stock Exchange (OSE), transferring from the current listing […]
Read more

LIFE – Progress towards pilot production and automatization

February 14, 2024
Bergen, Norway, 14 February 2024: Lifecare AS (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), has successfully finished the first and important step of software implementation and coding for the upcoming automated pilot production. In addition to this Lifecare has received confirmation of delivery of essential equipment. Reference […]
Read more

LIFE – Appointment of Production Manager

February 1, 2024
Bergen, Norway, 1 February 2024: Lifecare AS (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), has appointed Torsten Ernst as Production Manager effective 1 March 2024. This appointment will strengthen our production team. Ernst is an industry specialist with a track record in making new solutions manufacturable, and […]
Read more

Stock Exchange Notification – Lifecare – Appointment of CFO

January 23, 2024
Bergen, Norway, 23 January 2024: Lifecare AS (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), has appointed Renete Kaarvik as Chief Financial Officer effective 1 Mai, 2024. Kaarvik joins Lifecare from the position as Global Finance Officer at Grieg Seafood ASA, a position she has held for close […]
Read more

LIFE – Successfully ISO 13485 certified

January 9, 2024
Bergen, Norway, January 9th, 2024: Today, Lifecare AS (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), can disclose that Lifecare Laboratory (Mainz, Germany) has received the official documentation for ISO 13485 certification. Reference is made to Lifecare’s stock exchange notification 27th of November 2022 when the ISO 13495 […]
Read more

LIFE: Letter from CEO – Happy New Year

January 3, 2024
The technology development and company progress were fantastic in 2023. We expect nothing less in 2024, in our mission to make life easier for patients and pets with diabetes. One year ago, we communicated Lifecare’s focus in 2023 to continue the core product development, achieve ISO 9001 and ISO 13485 certifications and production preparations. Furthermore, […]
Read more

LIFE: Prof. Dr. Tony James joining Lifecare’s Scientific Advisory Board

December 19, 2023
Professor Dr. Tony James will join Lifecare’s Scientific Advisory Board. – We have collaborated with Professor Tony James since 2019, and we are really excited to bring him on board in this position, says CEO Joacim Holter. Tony James is professor of Chemistry at the University of Bath and Fellow of the Royal Society of Chemistry. He […]
Read more

LIFE: CSO – Switch from consultancy agreement to employee

December 15, 2023
Bergen, Norway, December 15th, 2023, Today, Lifecare AS (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), informs that the formal relationship with the Company’s Chief Scientific Officer (CSO) will be adjusted from an consultancy agreement to an employment agreement. Since 2013, Prof. Dr. Dr. Med. Andreas Pfützner has […]
Read more